Inoue, K., Masumoto, M., Wakakura, M., & al, e. (2011). Ocular hypotensive effect, preservation of visual fields, and safety of adding dorzolamide to prostaglandin therapy for twelve months. Dove Medical Press.
Chicago Style (17th ed.) CitationInoue, Kenji, Mieko Masumoto, Masato Wakakura, and et al. Ocular Hypotensive Effect, Preservation of Visual Fields, and Safety of Adding Dorzolamide to Prostaglandin Therapy for Twelve Months. Dove Medical Press, 2011.
MLA (8th ed.) CitationInoue, Kenji, et al. Ocular Hypotensive Effect, Preservation of Visual Fields, and Safety of Adding Dorzolamide to Prostaglandin Therapy for Twelve Months. Dove Medical Press, 2011.
Warning: These citations may not always be 100% accurate.